Clinical Trial Update: The Application of mRNA Immunotherapy Technology in Refractory Malignancies Associated With Epstein-Barr Virus (EBV) [NA]

View source ↗

Summary

This clinical trial update describes the use of mRNA immunotherapy to treat Epstein-Barr virus–associated malignancies, with the study currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus-associated Malignancies

Drugs mentioned

• mRNA immunotherapy

Snippet

Sponsor: West China Hospital | Conditions: EBV-associated Tumors | NA | Status: NOT_YET_RECRUITING